Registry of Lobbyists
Version 6 of 8 (2005-08-19 to 2006-02-28) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.
| Corporation: |
MERCK FROSST CANADA LTD.
16711 TRANSCANADA HIGHWAY KIRKLAND, QC H9H 3L1 Canada |
| Telephone number: | 514-428-2638 |
| Fax number: | 514-428-2662 |
| Responsible officer name and position during the period of this registration: | ANDRÉ MARCHETERRE, PRESIDENT |
| Description of activities: | Merck Frosst Canada Ltd. is a research-driven pharmaceutical company developing, manufacturing and marketing a broad range of innovative medicines to improve human health. The Merck Frosst Centre for Therapeutic Research has the mandate to discover new therapies for the treatment of respiratory diseases, inflammatory diseases, diabetes and osteoporosis. We are committed to fostering partnerships to deliver the most valuable health outcomes for Canadian patients. Based in Montréal, Quebec, we employ nearly 1,900 people including more than 300 of the world's leading scientific personnel. We are firmly committed to science education and sponsor a number of programs designed to spark young people's interest in science. |
| The client is a subsidiary of the following parent companies: |
MERCK & CO. INC.
ONE MERCK DRIVE, P.O. BOX 100 WHITEHOUSE STATION, NJ United States of America 08889-0100 |
| Coalition | The corporation is not a member of a coalition. |
| Subsidiary: | The corporation does not have any subsidiaries that could be affected by the outcome of the undertaking. |
| Other direct interests | The corporation's activities are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking. |
| Was the corporation funded in whole or in part by any domestic or foreign government institution in the last completed financial year? | No |
| Name: | François Bertrand |
| Position title: | Executive Director, Medical Research |
| Public offices held: | No |
| Name: | Christian Blouin |
| Position title: | Director, Public Health |
| Public offices held: | No |
| Name: | Robert Davies |
| Position title: | Vice President, Customer Partnering Unit, West |
| Public offices held: | No |
| Name: | Denis Drolet |
| Position title: | Government Affairs, Manager |
| Public offices held: | No |
| Name: | Kirk Duguid |
| Position title: | Vice President, Finances & Business Excellence |
| Public offices held: | No |
| Name: | Lyne Fortin |
| Position title: | Vice President, Customer Partnership Planning |
| Public offices held: | No |
| Name: | Roger Fournier |
| Position title: | Executive Director, Business, Intelligence & I.T. Services |
| Public offices held: | No |
| Name: | Richard Garant |
| Position title: | Executive Director, Customer Partnering Unit, East |
| Public offices held: | No |
| Name: | Stephen Girouard |
| Position title: | Executive Director, Customer Partnering Unit, Central |
| Public offices held: | Yes |
| Name: | Bernard Houde |
| Position title: | Vice President, Strategic Planning, Stakeholders & Corporate Counsel |
| Public offices held: | No |
| Name: | Philippe Hébert |
| Position title: | Vice President, Strategic Planning, Customers |
| Public offices held: | No |
| Name: | Mike Lamothe |
| Position title: | Vice President, Human Resources |
| Public offices held: | No |
| Name: | Robert Livingston |
| Position title: | Federal Government Affairs Director |
| Public offices held: | No |
| Name: | André Marcheterre |
| Position title: | President |
| Public offices held: | No |
| Name: | Sam McClintock |
| Position title: | Executive Director, PR&D |
| Public offices held: | No |
| Name: | Kathleen Metters |
| Position title: | Vice President, MRL |
| Public offices held: | No |
| Name: | Terrence Montague |
| Position title: | Vice President, Customer Services Planning |
| Public offices held: | Yes |
| Name: | Mike Pelini |
| Position title: | Vice President, MMD |
| Public offices held: | No |
| Name: | Don Soule |
| Position title: | Vice President, Patient/Product Planning Gr. 1 |
| Public offices held: | No |
| Name: | Gregg Szabo |
| Position title: | Executive Director, Corporate Affairs |
| Public offices held: | No |
| Name: | Leo Van Dijk |
| Position title: | Manager, Corporate Affairs, Eastern Canada |
| Public offices held: | No |
| Federal departments or organizations which have been or will be communicated with during the course of the undertaking: | Canadian International Development Agency (CIDA), Canadian International Trade Tribunal (CITT), Federal Office of Regional Development – Quebec (FORD[Q]), Foreign Affairs and International Trade Canada (DFAITC), Health Canada (HC), Industry Canada, Justice Canada (JC), National Research Council (NRC), Patented Medicine Prices Review Board (PMPRB), Procurement Review Board of Canada (PRB), Solicitor General Canada (SGC) | ||||||
|
Communication techniques that have been used or are expected to be used in the course of the undertaking:
|
Informal communications, Meetings, Presentations, Telephone calls, Written communications, whether in hard copy or electronic format | ||||||
| Subject Matter: Areas of Concern: | Constitutional Issues, Health, Industry, Intellectual Property, Internal Trade, International Relations, International Trade, Justice and Law Enforcement, Science and Technology | ||||||
| Subject Matter: Retrospective: | Communication with public office holders in relation to: changes to patent legislation (generally); discussions regarding National Pharmacare; and health policies (generally); and vaccines, particularly concerning access, increased funding for public health including vaccination, advocating for vaccine use as a health prevention tool, and the improvement of the procurement system for vaccines in Canada. | ||||||
| Subject Matter: Prospective: | Communication with public office holders in relation to: changes to patent legislation (generally); discussions regarding National Pharmacare; and health policies (generally); and vaccines, particularly concerning access, increased funding for public health including vaccination, advocating for vaccine use as a health prevention tool, and the improvement of the procurement system for vaccines in Canada. | ||||||
Details Regarding the Identified Subject Matter
|
|||||||